Alendronate prevents further bone loss in renal transplant recipients. - Wikidata - wikimedia - TriplyDB

Alendronate prevents further bone loss in renal transplant recipients.

Alendronate prevents further bone loss in renal transplant recipients.

http://www.wikidata.org/entity/Q43791666

about

Interventions for preventing bone disease in kidney transplant recipients Bisphosphonates: mechanism of action and role in clinical practice Efficacy and Safety of Bisphosphonates for Low Bone Mineral Density After Kidney Transplantation: A Meta-Analysis Use of alendronate sodium (Fosamax) to ameliorate osteoporosis in renal transplant patients: a case-control study Management of mineral and bone disorder after kidney transplantation.Vitamin D in organ transplantation Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.Effect of kidney transplantation on bone.Bisphosphonates and bone fractures in long-term kidney transplant recipients Transplantation osteoporosis.Post-transplantation osteoporosis.Therapeutic management of post-kidney transplant hyperparathyroidism.Osteoporosis after transplantation.Bone disease after transplantation: osteoporosis and fractures risk.Bisphosphonates for preventing bone disease in kidney transplant recipients: a meta-analysis of randomized controlled trials.Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice.Bone Disease after Kidney Transplantation.Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial.Efficacy and Safety of Different Bisphosphonates for Bone Loss Prevention in Kidney Transplant Recipients: A Network Meta-Analysis of Randomized Controlled Trials.

P2860

Q24243851-AF115AE5-1DA7-4DE5-B5DE-139E7C47945A Q24644708-5E7CB919-2D33-425C-9F99-8BAB0A1EBF21 Q26769030-7FC3C4A4-C607-462C-B804-61855D0E2B1D Q28485278-BA975003-DEBE-4414-9752-B4A21735C3E3 Q30418461-F16AE329-A4D0-4635-9D0D-15E5F6EB2BC0 Q34069825-CA1CBD98-31EE-4AF3-9CD6-F5D88E461C45 Q35026446-00D86221-DE9B-462D-9088-BAE341BBE3C5 Q36554790-844EF396-124C-43D3-9917-1FF226FCE494 Q36606360-397BCFFA-E6A7-4EB6-93B6-CCE89777E843 Q36658975-C20F2473-A2B6-43D6-9CF3-330AF09F88D4 Q37756580-C69D25DE-B5D3-4F0F-99BB-E68548F4E438 Q37767247-DBF7FF3E-371F-49C4-A24D-C8094C2B30C6 Q37968224-48DC3B73-179D-449C-8E1B-2D8831622EA4 Q38244168-32FFB9A5-294A-4274-96A8-8DF30BD882D1 Q38586746-184D1E6B-C4B3-4974-8F34-397AC79902D6 Q39271486-168A47C5-02ED-40C2-8E28-895292A3FDEC Q39970839-8E86F0BD-EAB7-4995-8C1D-A3A954F072C0 Q42353384-D43FDD43-D856-4543-93ED-C8EEE80F6264 Q55340884-06CC8150-FC85-4EAA-AEB3-ECD1C8790F51

P2860

Alendronate prevents further bone loss in renal transplant recipients.

http://www.wikidata.org/entity/Q43791666

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Alendronate prevents further bone loss in renal transplant recipients.

@en

Alendronate prevents further bone loss in renal transplant recipients.

@nl

type

label

Alendronate prevents further bone loss in renal transplant recipients.

@en

Alendronate prevents further bone loss in renal transplant recipients.

@nl

prefLabel

Alendronate prevents further bone loss in renal transplant recipients.

@en

Alendronate prevents further bone loss in renal transplant recipients.

@nl

P1433

Q43791666-EBA613B4-D1E8-4335-BAB9-4574E55920BC

P1476

Q43791666-584F87EC-46B8-49B3-8254-1011501CA260

P2093

Q43791666-0B47A8BA-010B-436C-A6C7-5BD1DAB9F8C3

Q43791666-1BCD0E7E-4062-47E2-814C-BAD0138D2835

Q43791666-3D246999-455B-4738-921F-55F950497110

Q43791666-400CCB48-14E3-4F73-8166-35E41E2FE538

Q43791666-5BFFF600-F79C-4B55-9504-A10FD0D11772

Q43791666-79FB52C5-204A-4E0F-9665-71AA8EFAE7A6

Q43791666-9D8BDA97-BEA7-4B39-A841-5FAFE732478E

Q43791666-ADB4DD86-BFDF-447E-AB7B-E93835854EBB

Q43791666-B1D9AFE7-00B5-4102-B90E-6071995625F5

Q43791666-B62BC81D-CB57-4D8A-A7DC-FDACA737EA69

P2860

Q43791666-944EBE3A-5F04-4D7A-BE67-9E23F0C69BEF

P304

Q43791666-184586A0-3DF7-4EC4-BF9B-FCAD5E160E3C

P31

Q43791666-F1F05B0C-8BEC-481E-AB73-4F9C6BC1E4A7

P356

Q43791666-DB2A2163-E7D5-4FD5-B320-D44B3157A402

P433

Q43791666-8ACA83CA-7BFE-448B-9DC1-4216881D5250

P478

Q43791666-715B3A1D-24EB-4EFA-B08F-F326F201E5F6

P50

Q43791666-CF3D54AE-F2E0-4729-9E2C-4B200C90BA64

P577

Q43791666-58B5000B-36D8-4AF0-B8E8-6C067CC2AB74

P5875

Q43791666-07CA8C67-D106-49ED-A635-3749B5C65271

P698

Q43791666-77BC8914-F6C0-4DA8-BE38-AA8C16DB7F20

P356

JBMR.2001.16.11.2111

P1433

Journal of Bone and Mineral Research

P1476

Alendronate prevents further bone loss in renal transplant recipients

@en

P2093

Bonfante L

http://www.w3.org/2001/XMLSchema#string

Carraro G

http://www.w3.org/2001/XMLSchema#string

Crepaldi G

http://www.w3.org/2001/XMLSchema#string

D'Angelo A

http://www.w3.org/2001/XMLSchema#string

Dalle Carbonare L

http://www.w3.org/2001/XMLSchema#string

Giannini S

http://www.w3.org/2001/XMLSchema#string

Marchini F

http://www.w3.org/2001/XMLSchema#string

Nobile M

http://www.w3.org/2001/XMLSchema#string

Sartori L

http://www.w3.org/2001/XMLSchema#string

Zaninotto M

http://www.w3.org/2001/XMLSchema#string

P2860

Musculoskeletal complications after renal transplantation: pathogenesis and treatment.

P304

2111-2117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.2001.16.11.2111

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11656305

http://www.w3.org/2001/XMLSchema#string

P698

11697808

http://www.w3.org/2001/XMLSchema#string